147 related articles for article (PubMed ID: 34813915)
1. Detection of molecular signatures and pathways shared by Alzheimer's disease and type 2 diabetes.
Shu J; Li N; Wei W; Zhang L
Gene; 2022 Feb; 810():146070. PubMed ID: 34813915
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
[TBL] [Abstract][Full Text] [Related]
3. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.
Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X
Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959
[TBL] [Abstract][Full Text] [Related]
4. A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases.
Rahman MH; Peng S; Hu X; Chen C; Rahman MR; Uddin S; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041280
[TBL] [Abstract][Full Text] [Related]
5. Identification of dysregulated genes and pathways of different brain regions in Alzheimer's disease.
Wang Y; Wang Z
Int J Neurosci; 2020 Nov; 130(11):1082-1094. PubMed ID: 32019384
[No Abstract] [Full Text] [Related]
6. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
Li J; Xu C; Zhang J; Jin C; Shi X; Zhang C; Jia S; Xu J; Gui X; Xing L; Lu L; Xu L
Neurochem Res; 2021 Apr; 46(4):964-979. PubMed ID: 33586092
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of differential gene expression profiles in hippocampi to identify candidate genes involved in Alzheimer's disease.
Hu W; Lin X; Chen K
Mol Med Rep; 2015 Nov; 12(5):6679-87. PubMed ID: 26324066
[TBL] [Abstract][Full Text] [Related]
9. The common genes involved in the pathogenesis of Alzheimer's disease and type 2 diabetes and their implication for drug repositioning.
Yuan X; Wang H; Zhang F; Zhang M; Wang Q; Wang J
Neuropharmacology; 2023 Feb; 223():109327. PubMed ID: 36368623
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hub Genes Related to Alzheimer's Disease and Major Depressive Disorder.
Cheng Y; Sun M; Wang F; Geng X; Wang F
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211046123. PubMed ID: 34732058
[TBL] [Abstract][Full Text] [Related]
11. Exploring the pathogenetic association between schizophrenia and type 2 diabetes mellitus diseases based on pathway analysis.
Liu Y; Li Z; Zhang M; Deng Y; Yi Z; Shi T
BMC Med Genomics; 2013; 6 Suppl 1(Suppl 1):S17. PubMed ID: 23369358
[TBL] [Abstract][Full Text] [Related]
12. Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses.
Shu J; Wei W; Zhang L
Front Mol Neurosci; 2022; 15():751044. PubMed ID: 35221911
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer's Disease.
Jing Q; Zhang H; Sun X; Xu Y; Cao S; Fang Y; Zhao X; Li C
Biomed Res Int; 2021; 2021():8893553. PubMed ID: 33506048
[TBL] [Abstract][Full Text] [Related]
14. Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases.
Caberlotto L; Nguyen TP; Lauria M; Priami C; Rimondini R; Maioli S; Cedazo-Minguez A; Sita G; Morroni F; Corsi M; Carboni L
Sci Rep; 2019 Mar; 9(1):3965. PubMed ID: 30850634
[TBL] [Abstract][Full Text] [Related]
15. The Bioinformatic Analysis of the Dysregulated Genes and MicroRNAs in Entorhinal Cortex, Hippocampus, and Blood for Alzheimer's Disease.
Pang X; Zhao Y; Wang J; Zhou Q; Xu L; Kang D; Liu AL; Du GH
Biomed Res Int; 2017; 2017():9084507. PubMed ID: 29359159
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes.
Shen J; Zhu B
Mol Med Rep; 2018 Jun; 17(6):7636-7644. PubMed ID: 29620215
[TBL] [Abstract][Full Text] [Related]
17. Linking Alzheimer's disease and type 2 diabetes: Novel shared susceptibility genes detected by cFDR approach.
Wang XF; Lin X; Li DY; Zhou R; Greenbaum J; Chen YC; Zeng CP; Peng LP; Wu KH; Ao ZX; Lu JM; Guo YF; Shen J; Deng HW
J Neurol Sci; 2017 Sep; 380():262-272. PubMed ID: 28870582
[TBL] [Abstract][Full Text] [Related]
18. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Alzheimer's disease and type 2 diabetes using non-negative matrix factorization.
Chung Y; Lee H;
Sci Rep; 2021 Jul; 11(1):15265. PubMed ID: 34315930
[TBL] [Abstract][Full Text] [Related]
20. Systematically analyses of the common dysregulated networks to understand the common pathologies between T2D and atherosclerosis.
Lin Z; Yang F; Sun L; Gao J; Cao Y; Qiu H; Zhan X
Gene; 2018 Sep; 671():110-116. PubMed ID: 29705125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
